Farges, Olivier

Publishing since 1992 (Senior)

Has published 89 publications in 19 years

Number of publications published per year by Farges, Olivier. (Source : PubMed)

Distribution of publications types for Farges, Olivier. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ozenne V, Paradis V, Pernot S, Castelnau C, Vullierme MP, Bouattour M, Valla D, Farges O, Degos F. Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib.  Eur J Gastroenterol Hepatol  2010  
•  Farges O. Intrahepatic cholangiocarcinoma.  Gastroenterol. Clin. Biol.  2010;34;3  
•  Farges O, Fuks D. Clinical presentation and management of intrahepatic cholangiocarcinoma.  Gastroenterol. Clin. Biol.  2010;34;3  
•  Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.  Gastroenterology  2009;137;5  
•  Guedj N, Zhan Q, Perigny M, Rautou PE, Degos F, Belghiti J, Farges O, Bedossa P, Paradis V. Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.  J. Hepatol.  2009;51;1  
•  Dreyer C, Le Tourneau C, Faivre S, Qian Z, Degos F, Vuillerme MP, Paradis V, Hammel P, Ruszniewski P, Cortes A, Farges O, Belghiti J, Valla D, Raymond E. [Cholangiocarcinoma: epidemiology and global management]  Rev Med Interne  2008;29;8  
•  Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V, Belghiti J. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant.  J. Gastrointest. Surg.  2008;12;2  
•  Toouli J, Farges O, Huma A, Ardhanari R, Werner J. Editorial.  HPB (Oxford)  2008;10;5  
•  Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, Tellier Z, Guichard C, Ogier-Denis E, Poynard T, Moreau R, Lebrec D. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.  Hepatology  2007;46;6  
•  Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de Ledinghen V, Francoz C, Sauvanet A, Vilgrain V, Belghiti J, Durand F, Valla D. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome.  Hepatology  2006;44;5  

[ See timeline ] [ See all publications ]